Andrew Hill Investment Advisors Highlights Q4 2025 Portfolio Moves: Double-Digit Gains, New Positions, and Strategic Portfolio Adjustments
ByAinvest
Thursday, Jan 8, 2026 10:23 pm ET1min read
COST--
FHN--
TMO--
Andrew Hill Investment Advisors reported a third consecutive year of double-digit gains in 2025, with gold investments outperforming the broader market. The firm expanded its portfolio by adding positions in financial and healthcare sectors, including First Horizon (FHN) and Thermo Fisher Scientific (TMO). Costco (COST) was sold for tax loss purposes. The company's performance was driven by steady revenue growth, strong profitability, and conservative leverage.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet